iifl-logo-icon 1

Astec Lifesciences Ltd Board Meeting

748.15
(5.54%)
Mar 6, 2025|03:31:05 PM

Astec Lifescienc CORPORATE ACTIONS

07/03/2024calendar-icon
07/03/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting27 Jan 202520 Jan 2025
Quarterly Results ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 ,inter alia, to consider and approve Kindly find enclosed the prior intimation of the Company. Please find enclosed intimation for conduct of Postal Ballot for seeking Approval of Shareholders for Re-appointment of Independent Director. Please find enclosed the intimation of proposed acquisition of 26% Equity shareholding in proposed Special Purpose Vehicle (As per BSE Announcement Dated on 27/01/2025)
Board Meeting25 Oct 20249 Oct 2024
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Kindly find enclosed the prior intimation of the Company. Please find enclosed outcome of the Board Meeting dated October 25, 2024 (As per BSE Announcement Dated on 25/10/2024)
Board Meeting29 Jul 202418 Jul 2024
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Intimation of Board Meeting as per Regulations 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Kindly find enclosed the Outcome of the Board Meeting held on Monday, July 29, 2024. Kindly find enclosed the Outcome of Board Meeting held on July 29, 2024. (As Per BSE Announcement dated on 29.07.2024)
Board Meeting2 May 202424 Apr 2024
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter and Financial Year ended 31st March 2024 after these results are reviewed by the Audit Committee. Please find enclosed outcome of Board Meeting held on 2nd May, 2024 Please find attached Audited Financial Results for the Quarter and Financial Year ended March 31, 2024 Please find enclosed intimation of resignation of Chief Financial Officer with effect from the closure of business hours on 3rd May, 2024 Please find enclosed intimation of resignation of Mr. Vijay K. Khot, Independent Director of the Company with effect from closure of business hours on 2nd May, 2024 Please find enclosed the intimation of cessation of Directorship of Mr. Vijay K. Khot, Independent Director of the Company, with effect from the closure of business hours on 2nd May, 2024. The 30th (Thirtieth) Annual General Meeting of the Company will be held on Monday, 29th July, 2024, at 4.00 p.m. (IST) by Video Conference / Other Audio Visual Mode. (As Per BSE Announcement Dated on 02/05/2024)

Astec Lifescienc: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.